Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MPO | P05164 | 1/20 | 0.42 |
| ▸ | MIF | P14174 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.40 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 2/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | NOS2 | P35228 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL777528 | 0.85 | LMNA (0.50) | LMNATDP1MPOMIFTAAR1 | |
| SCHEMBL13654815 | 0.83 | LMNA (0.48) | LMNATDP1MPOMIFTAAR1 | |
| SCHEMBL12381822 | 0.81 | LMNA (0.46) | LMNATDP1MPOMIFTAAR1 | |
| SCHEMBL777529 | 0.81 | LMNA (0.46) | LMNATDP1MPOMIFTAAR1 | |
| SCHEMBL775566 | 0.81 | AOC3 (0.44) | LMNATDP1TAAR1HTR2AHRH1 | |
| SCHEMBL29346087 | 0.81 | LMNA (0.46) | LMNATDP1MPOMIFTAAR1 | |
| SCHEMBL8813120 | 0.81 | LMNA (0.46) | LMNATDP1MPOMIFTAAR1 | |
| SCHEMBL24023128 | 0.79 | LMNA (0.45) | LMNATDP1MPOMIFTAAR1 | |
| SCHEMBL27503288 | 0.79 | LMNA (0.45) | LMNATDP1MPOMIFTAAR1 | |
| SCHEMBL8379408 | 0.79 | ALDH1A1 (0.46) | LMNATDP1MPOMIFHKDC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118852618-A | Resin composition | 旭化成株式会社 | 2024-10-29 | — | — | CN | claimed |
| EP-3527593-B1 | ISOCYANATE COMPOSITION, METHOD FOR PRODUCING ISOCYANATE COMPOSITION, AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-23 | — | — | EP | disclosed |
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| CN-118852618-A | Resin composition | 旭化成株式会社 | 2024-10-29 | — | — | CN | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| EP-3848399-B1 | TRANSITION METAL COMPOUND AND METHOD FOR PRODUCING OLEFIN POLYMER | IDEMITSU KOSAN CO (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-11795188-B2 | Transition metal compound and method for producing olefin polymer | IDEMITSU KOSAN CO., LTD. (JP) | 2023-10-24 | — | — | US | disclosed |
| CN-116885175-A | Lithium ion battery | 中创新航科技集团股份有限公司 | 2023-10-13 | — | — | CN | disclosed |
| US-20230235202-A1 | PLASTICIZER FOR RESINS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| CN-113929866-B | Modified resin and resin composition | 旭化成株式会社 | 2023-07-07 | — | — | CN | disclosed |
| US-20100036066-A1 | ALPHA-OLEFIN POLYMER AND PROCESS FOR PRODUCTION THEREOF | IDEMITSU KOSAN CO., LTD. (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20090325065-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| EP-2113521-A1 | -OLEFIN POLYMER AND PROCESS FOR PRODUCTION THEREOF | Idemitsu Kosan Co., Ltd. (JP) | 2009-11-04 | — | — | EP | disclosed |
| EP-2012386-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
| EP-1836251-A1 | STABILIZER COMPOSITION CONTAINING PHOSPHITE ESTERS | Baerlocher Italia S.p.A. (IT) | 2007-09-26 | — | — | EP | disclosed |
| WO-2006066947-A1 | STABILIZER COMPOSITION CONTAINING PHOSPHITE ESTERS | BAERLOCHER ITALIA S.P.A. (IT) | 2006-06-29 | — | — | WO | disclosed |
| US-20050192401-A1 | Aid and method for processing thermoplastic polymer compositions | BAERLOCHER GMBH | 2005-09-01 | — | — | US | disclosed |
| US-20050040367-A1 | A liquid stabilizer of an organic onium perchlorate and an organic solvent for the stabilization of halogen-containing polymers to improve the starting color; reduction of cloudiness in highly transparent end products, e.g., hard or soft Polyvinyl Chloride | BAERLOCHER GMBH | 2005-02-24 | — | — | US | disclosed |
| US-4330302-A | DIBENZOTHIOPHENES AND AMINES OR CARBAZOLES AS ADDITIVES | EXXON RESEARCH & ENGINEERING CO. (US) | 1982-05-18 | — | — | US | disclosed |
| US-4280894-A | ADDING DIBENZOTHIOPHENES, AMINES OR CARBAZOLES PRODUCES BLENDS SUITABLE FOR USE AS JET FUELS | EXXON RESEARCH & ENGINEERING CO. (US) | 1981-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795188-B2 | Transition metal compound and method for producing olefin polymer | H1-0, C9, C5 | LMNA 1550/4885TDP1 4384/4885MPO 364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.